When: Price in $363-366 resistance zone

Then: Scale sells opportunistically over 1-2 sessions, not single print

HOLD core position; trim maximum 15% only if price closes below $340 on volume or below the 200-day moving average; do not short or sell short-dated puts; if using a stop-loss, set it at $325 sized to the $6 ATR rather than above entry at $375

• Stop at $375 is above entry at $360, structurally inconsistent with stated $280-$310 bear case downside
• Q2 2026 EPS included ~$4.4 billion one-time benefit; stripping this, JPM still earned ~$17.8 billion in a single quarter vs ~$14.3B 2025 quarterly average (25% above historical pace)
• ROE is 17.79% and operating margin is over 50%—best-in-class metrics for a $5 trillion balance sheet bank
• Technical setup is neutral with bullish lean: 50-day rising, 200-day rising, price >13% above 200 SMA
• MACD histogram compressed from -1.92 to -0.056, indicating bearish momentum exhausting
• RSI made higher low while price made lower low—desk technician calls it potential bullish divergence inside healthy consolidation
• Stock trading at 14x forward earnings with 7% forward EPS growth and 17%+ ROE; multiple compression requires recession or credit event
• Polymarket pricing 6% odds of recession by year-end; loan book up 36% over 4 years but NCOs and charge-offs remain benign with unemployment low and payrolls +162K
• G-SIB surcharge escalation is stale—known for three years during which JPM rallied from high $200s to $358
• Buyback pace at record; holding is the low-risk path

→ vs aggressive: Trade structure places stop at $375 above the $360 entry, which is inconsistent with the $280-$310 downside target—if the thesis is correct, the stop will be irrelevant on the way down

→ vs aggressive: MACD compression, RSI bullish divergence, and rising 50/200-day moving averages indicate bearish momentum exhausting, not building; the technician calls it a potential bullish divergence in a healthy consolidation

→ vs aggressive: The 5-7% upside cap assumes resistance at $366 is permanent and multiple compresses, but 14x forward P/E with 7% EPS growth and 17%+ ROE does not compress without a recession or credit event

→ vs aggressive: Pricing the downside tail as the base case is what gets risk managers fired; Polymarket puts recession odds at 6%

→ vs aggressive: Credit cycles start when NCOs tick up and charge-offs broaden, not when loan books grow in a benign credit environment with low unemployment

→ vs aggressive: G-SIB surcharge is stale—already factored in during three years of JPM rallying from high $200s to $358

Trim 20-25% of position into $363-366 resistance; eliminate stop-loss; deploy conditional re-entry triggers at $366 breakout (7M+ volume) or $340 drawdown; park capital in cash/short-duration until Q3 earnings mid-October

• JPM peaked at $365.18 on August 12 with bearish MACD crossover two days later; RSI declined from 68.92 to mid-50s without bullish crossover
• 4.87 million volume into 52-week high versus 6-7 million average indicates below-average participation at resistance
• Q2 normalized earnings of $17.8 billion run 25% above 2025 quarterly average; annualized represents ~$71 billion on $5 trillion balance sheet
• Polymarket recession odds at 6% by year-end and August payroll of 162,000 support soft-landing/no-landing regime
• Hawkish Fed pricing of 93% no-cuts supports NII for JPM, not compression
• G-SIB escalation is structural constraint that compounds when franchise hits tougher revenue environment
• 2025 buyback pace of $34.6 billion is not assured; treating it as price floor is questionable assumption
• Trading range bound between $350 and $366; scaling sells into resistance ($363-366) preferred over single print at $360
• Position at 52-week high in deteriorating momentum regime carries real cost even without imminent fundamental breakdown
• Q3 earnings in mid-October typically widens implied volatility, creating either buying opportunity on disappointment or confirmation of franchise sustainability

→ vs aggressive: The '13-22% downside versus 5-7% upside' framing is narrative not math—asserting $366 as permanent resistance, multiple compression, and credit cycle inflection are unproven assumptions; Polymarket shows only 6% recession odds and hawkish Fed actually supports NII; pricing bear case as base case while macro supports soft-landing is directional bet disguised as probability argument

→ vs aggressive: Cannot simultaneously argue franchise is deteriorating into credit crisis AND that Q2 normalized earnings of $17.8 billion are unimpressive when they run 25% above 2025 quarterly average; record underlying earnings contradicts bear case thesis

→ vs conservative: Sell at $360 with stop at $375 is not disciplined trim but momentum-fade short with upside stop; if bear case conviction were genuine, stopping 15 dollars above entry contradicts the thesis

→ vs conservative: 'Hold the core' is not a free option; position at 52-week high in deteriorating momentum with structural headwinds carries real cost; exit anchoring to 200-day or $340 is after-the-fact risk management since by the time those levels are hit, the fundamental story has already broken

→ vs conservative: Dismissal of G-SIB escalation as 'stale' is lazy analysis; JPM rallying through three years of G-SIB increases doesn't mean constraint isn't real—it means franchise strength was offsetting it, and that offset weakens in tougher revenue environment with credit normalization